For research use only
| Cat No. | ABC-KH068Y |
| Product Type | Knockdown Stable Cell Line |
| Species | Human |
| Host Cell | DLD-1 |
| Source Organ | Large intestine |
| Disease | Adenocarcinoma; Colorectal; Dukes’ type C |
| Storage | Liquid Nitrogen |
Human KRAS (+/-) DLD-1 Cell line is knockdown of mutant KRAS allele in heterozygous parental cells
Human KRAS (+/-) DLD-1 Cell Line is a genetically engineered cell line derived from heterozygous KRAS-mutant DLD-1 parental cells, in which the mutant KRAS allele has been specifically knocked out (KO). It retains the wild-type allele, providing an ideal isogenic model for investigating KRAS oncogene function, signaling pathways, and evaluating targeted therapies, effectively eliminating interference from divergent genetic backgrounds.
| Species | Human |
| Cat.No | ABC-KH068Y |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Large intestine |
| Disease | Adenocarcinoma; Colorectal; Dukes’ type C |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Knockdown Stable Cell Line |
| Host Cell | DLD-1 |
| Stock | Custom |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).